Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Unique take on depression has people feeling good—about feeling bad


https://www.prweb.com/

Book cover for THE INVENTION OF EVERYTHING: Insights on Life, Food, and one good Thermos.

“Being a part of those around us is the agreement you sign when you join the human race.”

“It was very unexpected,” says author Everett De Morier. “This article took on a life of its own.”

Everett De Morier is a humorist and award-winning author who, for the past three years, has been editor-in-chief of 543 Magazine. And this week, De Morier posted an article about depression in middle-aged people.

“I mean, the piece was a lot more personal than I like to get,” said De Morier. “I had to admit some things that I was struggling with, but overall I expected it to be read by the same amount of readers as all the other articles.”

543 Magazine has a solid number of loyal readers and even had its best-of articles turned into a book called The Invention of Everything: Insights on Life, Food, and One Good Thermos, published in 2018 by Blydyn Square Books. 543 Magazine also produced the 2018 documentary Binghamton: Valley of Creativity.

But the reaction to the article entitled “The Depression Agreement” was completely unexpected.

De Morier said, “The website had a small number of direct comments to the articles. People don’t usually comment on the site; they share on social media. But shortly after the article went live, my email exploded.”

In two days, “The Depression Agreement” received five times as many comments as the entire website had garnered in over three years. All of them were extremely positive.

“I guess it shows how important a topic depression is, but more importantly I think people responded to the fact that depression is a kind of a selfish act and we need to change that. And we do that be staying involved with those around us which leads to us actually feeling sort of good about feeling bad.”

“The Depression Agreement” article can be found at https://543magazine.com/the-depression-agreement/#disqus_thread

Share article on social media or email:

Triple W Wins HME Business 2019 New Product Award for DFree


https://www.prweb.com/

Triple W won the HME Business 2019 New Product Award for DFree®, the first health wearable device for urinary incontinence.

“We’re honored to be selected by HME Business,” said Ty Takayanagi, Vice President of Marketing & Business Development. “With DFree, people with incontinence can proactively manage their health condition and confidently socialize – knowing they’ll have plenty of time to plan for bathroom breaks.”

Triple W, an innovator of connected health devices, today announced it was named a winner of the HME Business 2019 New Product Award for DFree®, the first health wearable device for urinary incontinence. The award competition is sponsored by HME Business, the top business management media resource for home medical equipment (HME) professionals.

DFree is a non-invasive device that uses ultrasound technology to monitor bladder fullness and notifies you on your smartphone or tablet when it’s time to go to the bathroom via the DFree companion app. DFree stands for “diaper-free.” The HME Business New Product Award honors outstanding product development achievements by HME manufacturers and service providers. Fourteen winning products were selected in the sixth year of the program. DFree won in the “Incontinence & Urology Supplies” category. All entries are scored by a blind panel of judges from the HME provider community.

Winners will be recognized at Medtrade, the largest home medical equipment trade show and conference in the U.S. Medtrade Fall runs October 21-23 in Atlanta. Winners will also be featured on the HME Business website, hme-business.com, and will be featured in the November/December 2019 issue of HME Business magazine.

DFree helps to prevent accidental urinary leaks. Seniors and people with disability or provisional incontinence who need to manage a loss of bladder control now have an alternative to disposable diapers or pads and medications with the DFree health device. According to the U.S. National Institutes of Health, urinary incontinence affects 500 million people worldwide. DFree is designed not only to help people with urinary incontinence improve their quality of life and enable independence, but also to help reduce the burden for the caregivers.

“We’re honored to be selected by HME Business and included in this top group of product developers with significant innovative achievements,” said Ty Takayanagi, Vice President of Marketing and Business Development for Triple W. “With DFree, people with incontinence can proactively manage their health condition and confidently socialize and go about their daily activities – knowing they’ll have plenty of time to plan for bathroom breaks.”

Availability

DFree is available for purchase in the U.S. from the DFree website, Amazon and authorized retailers for $399.99 (MSRP). Triple W also offers rent-to-own option where customers can rent DFree from the DFree website for $40 per month with a minimum rental term of 30 days. Any rental fees paid will be applied towards purchase should customers decide to keep it. The DFree companion app may be downloaded for free from the App Store and Google Play. The app supports iOS devices (iPhone, iPad, iPod) running iOS version 10 or later and Android devices (phones, tablets) running Android 4.4 or later.

About Triple W

Triple W empowers people with incontinence to live without worries. Triple W believes that having control of your senses is the key to independence and living life to the fullest. The company was founded in 2015 and has offices in Tokyo and San Diego. DFree’s award-winning and patented technology is currently used in over 500 senior care facilities in Japan, Europe and the U.S. since 2017. For more information visit: https://www.dfreeus.biz/, LinkedIn, Facebook, Twitter and YouTube.

Notes:

D FREE is a registered trademark of Triple W Japan K.K. in the U.S. and other countries.

*DFree is not a medical device and is not intended to be used in the diagnosis, prevention, or treatment of diseases or conditions.

Share article on social media or email:



Better Therapeutics Publishes Study Estimating the Health Economic Impact of Digital Therapeutics in Type 2 Diabetes and Hypertension


Digital therapeutics that deliver behavioral interventions focused on root causes of chronic disease demonstrate clinical and cost benefits over traditional therapies.

Today, Better Therapeutics, a company developing prescription digital therapeutics for the treatment of cardiometabolic diseases, announced the publication of its fifth peer-reviewed study titled Estimating the impact of novel digital therapeutics in type 2 diabetes and hypertension: Health economic analysis.

“Chronic diseases including diabetes and heart disease affect half of all adults in the US and account for nearly 80 cents of every healthcare dollar spent. Digital therapeutics that deliver behavioral interventions focused on lifestyle demonstrate potential benefits over traditional therapies like medications and surgeries that treat the effects of disease while leaving the causes in place. They can increase patient access because they are inherently scalable, continuously delivered, and have demonstrated both clinical and cost-effectiveness in diabetes and hypertension,” said Kevin Appelbaum, CEO and study co-author.

The economic analysis estimated cost savings of $145 per patient per month (PPPM) in diabetes, and $97 PPPM in hypertension. These savings are realized by addressing the behaviors and lifestyle factors that are the root causes of disease, reducing the ongoing need for prescription medications. The potential cost savings increases substantially (30-60%) in moderately severe to severe patient populations. The intervention would be cost-effective at total three-year program costs of $6,468 for diabetes and $6,620 for hypertension.

Read the complete study here.

“Our analysis concluded that Better’s digital therapeutics for diabetic and hypertensive patients may provide substantial improvements in patient outcomes resulting in lower health resource utilization and costs, mostly resulting from decreased need for medications,” said health economist and lead author, Bob Nordyke, PhD.

About Better Therapeutics

Better develops prescription software for treating cardiometabolic diseases. By integrating elements of neuroscience, lifestyle medicine, and artificial intelligence, the company has created a new modality for treating a broad range of conditions that share common root causes. The company’s digital therapeutics have been validated in peer-reviewed and published clinical trials. Better is commercializing its disease reversal program with health plans, while pursuing regulatory approval of its first prescription digital therapeutic for treating type 2 diabetes. The company is headquartered in San Francisco, CA, and is a member of the Digital Therapeutics Alliance.

Share article on social media or email:

Dr. Gregory Levitin Named 2019 Top Patient Rated NYC Otolaryngologist by Find Local Doctors


News Image

I am always thrilled to be recognized by Find Local Doctors. My goal is to utilize my extensive training to provide effective, personalized treatment for all of my patients. Knowing that they are highly satisfied with the medical care I provide is extremely rewarding, says Dr. Gregory Levitin

Find Local Doctors has recently honored Dr. Gregory Levitin as a 2019 Top Patient Rated New York City Otolaryngologist. This recognition is based on five-star ratings and superior reviews from actual patients. Find Local Doctors is a trusted online directory that helps consumers easily locate top-notch, reputable physicians in their area. Dr. Levitin and his clinic New York Sinusitis Treatment is among an exclusive group of practices receiving a high volume of outstanding patient reviews.

Dr. Levitin is widely-known in New York City as the leading expert in providing treatment and relief of chronic sinusitis. His practice, New York Sinusitis Treatment, is located at 200 W. 57th Street, Suite 1410. He is a board-certified otolaryngologist and a fellow of the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS). In addition to running a private practice, he is also an assistant clinical professor in the Department of Otolaryngology at The New York Eye and Ear Infirmary. Dr. Levitin’s areas of expertise include endoscopic sinus surgery, allergies and chronic sinus disease, snoring and obstructive sleep disorders, tonsil and adenoid disease and voice disorders.

Using his experience as a head and neck surgeon, Dr. Gregory Levitin offers a range of treatments that are specifically designed to address the causes and symptoms of a number of conditions, including sinusitis. Dr. Levitin is an advocate of non-surgical or minimally invasive options for patients and specializes in providing balloon sinuplasty and Clarifix treatment. In addition, he also offers turbinate reduction surgery, Vivaer nasal airway remodeling and other procedures. Many patients have commented on Dr. Levitin’s warmth and professionalism. He is an outstanding physician who is devoted to his patients and extremely knowledgeable in his field.

“I am always thrilled to be recognized by Find Local Doctors. My goal is to utilize my extensive training to provide effective, personalized treatment for all of my patients. Knowing that they are highly satisfied with the medical care I provide is extremely rewarding,” says Dr. Gregory Levitin

More About Dr. Gregory Levitin

Dr. Levitin received his medical degree from the University of North Carolina School of Medicine and completed his residency in otolaryngology/head and neck surgery at The Mount Sinai Medical Center in New York City. Dr. Levitin is a fellow of the American College of Surgeons and a member of the American Medical Association. He has authored several medical journal articles, book chapters and has presented nationally in the field of otolaryngology. For more information about Dr. Gregory Levitin or his services at New York Sinusitis Treatment please visit https://www.sinusitistreatmentnyc.com or call (212) 784-6643.

Share article on social media or email:

Computers Made Effective/ 1st-Dragon Exhibiting at MGMA ’19 Helps Practice Managers Increase Physician Productivity using AI-powered Voice Recognition Solution


News Image

Using Dragon Medical One, Physicians report up to 54% increase in clinician productivity and 45% reduction of clinical documentation time.

The Computers Made Effective (CME)/ 1st-Dragon Solutions Team will once again be exhibiting at The MGMA 19 Annual Conference in New Orleans, Booth 1212, from October 13th through October 16th. “We are excited to continue our support of Medical Group Managers from all over the country. We look forward to empowering them with the latest technology and tools, to make working in their chosen EHR more efficient,” said Bonnie Saxman, President of Computers Made Effective.

No one works harder for the physician than the medical practice manager. Practice revenue and patient care are a dual focus for practice managers. Completed patient notes, for accurate and timely insurance reimbursement, is always top of mind. That is why the Solutions Team at CME seeks to make taking care of physicians more efficient and productive.

Nuance ® Dragon Medical One is focused on make documenting and completing patient notes as simple as possible. The AI-powered solution allows a user to create a single user profile that can be accessed across multiple Windows-based devices. The ease and portability of the solution allows a physician to start their notes right in their EHR, in the exam room using a microphone, add to the notes on their workstation, and even complete and submit the finished documentation via the PowerMic III, all at their convenience. Using Dragon Medical One, Physicians report up to 54% increase in clinician productivity and 45% reduction of clinical documentation time.

This year at MGMA 19, CME’s goal is two-fold, to re-engage with current group managers and update them on what new features have recently launched, as well as to introduce a suite of AI-powered solutions to new medical group managers. With the changes and advances in healthcare technology happening daily, it is important to ensure that practice managers and physicians have immediate access to the most up-to-date versions of software and cloud-based technology and that is what CME specializes in.

One of the latest features that CME will be introducing at MGMA is our “Super User Feature”. This enhancement to the AI-powered cloud-based speech recognition solution, Nuance ® Dragon Medical One, will make even the most skeptical physician a “Super EHR User” in a very short time. It is all about increasing medical practice productivity.

This year, the team will be conducting a drawing at MGMA 19 for a Nuance ®Power Mic III, with a retail value of $424. To schedule an in-booth demonstration of Dragon Medical One, please reach out to our Solutions Team. Contact us at Sales@1st-dragon.com or 866.977.3324 or 877.272.8280 or visit our website http://www.1st-dragon.com

Computers Made Effective (CME) is a trusted partner of Phillips, Olympus and is an Elite Level Nuance Partner with more than 20 years experience helping thousands of healthcare organizations customize Dragon Medical Solutions to enhance their clinical workflow. They specialize in offering a tailored approach to speech-to-text medical documentation to optimize EHR utilization in medical organizations of various sizes.

Share article on social media or email:

New to RX-Safety Oakley Prescription Safety Glasses and Sunglasses By Phillips Safety Research


News Image

RX-Safety has been selling both prescription safety glasses and general safety glasses for almost 20 years now online. We have never been able to carry Oakley Prescription Safety Glasses up to this point, in spite of demand, because the company has never had a line that was ANSI Z87+ certified. But the wait is over! Oakley now makes a complete line of safety glasses, all of which meet the ANSI Z87 safety rating requirements, and they are now available online at RX-Safety.com. We are proud to offer the full line of Oakley Prescription Safety Glasses and other Oakley Performance Glasses to our customers. But your question might be why do you need to wear prescription safety or sports glasses?

Prescription safety glasses and sunglasses are necessary proper safety gear for a whole host of activities people engage in every day. Whether you’re gearing up for a long motorcycle ride or earning your paycheck in an industrial environment that includes dangerous workplace hazards, safety glasses or prescription safety glasses are a crucial part of protecting your eyes and face in the long term. It’s critical that you take proactive steps to protect your eyes before they are exposed to serious damage.

What Do Safety Glasses Do?

Safety glasses are designed to provide a barrier between your eyes and harmful debris. That much might be obvious! However, there are very specific standards that safety glasses have to adhere to in order to be sold as certified safety glasses. The type of safety standards they must adhere to depends on the purpose and rating system standards they are held to.

What Kind of Standards Do Safety Glasses Have to Adhere To?

In fact, there aren’t any national standards for safety glasses, technically. However, there are standards that some companies choose to meet in order to prove that their products are certified to keep consumer’s eyes safe, and it also gives them a competitive edge.

The American National Standards Institute (ANSI) is a non-profit organization that encourages companies to create products that meet voluntary conformity standards in the United States. They oversee the development of American products, services, processes, and systems. ANSI creates a list of uniform standards that are attached to various products, such as prescription safety glasses. They also create testing guidelines to ensure that the products meet those standards. Their organization examines eyewear and judges whether it meets the durability standards it needs to in order to be considered certified. This stamp of approval means that the safety glasses created by the vendor can be used for a variety of uses including safety gear for employees that meets OSHA’s eye and face protection standards.

If an employer’s business exposes employees to potentially harmful substances, they are required to provide them with proper safety gear. However, employers aren’t allowed to simply hand out a pair of safety glasses to their employees at the door to the factory floor and call it a day. There is a strict set of rules for selecting the face and eye protection that complies with OSHA’s eye and face protection standard which is outlined here- 29 CFR 1910.133. For starters, eye protection has to be selected based on the hazard that employees need to be protected from. Safety glasses that provide adequate protection to an employee from impact might not be protective against chemicals. All personal protective equipment (PPE) has to be certified by the American National Standards Institute and the manufacturer has to legibly mark it as certified.

When Are Businesses Required to Issue Safety Glasses?

OSHA is designed to make sure that employees are not forced to work in unsafe environments. However, that doesn’t mean that businesses are not allowed to use potentially harmful materials. It just means that legally they are required to provide their employees with safety gear that will prevent them from the dangerous debris. Businesses are required to issue safety glasses to employees if there are any workplace hazards that can cause harm to your eyes. For instance, if an employee is working around any of the following substances, the employer is required to provide proper safety glasses according to OSHA standards:


  • Harmful chemical gasses or vapors
  • Flying particles
  • Excessive amounts of dust
  • Liquid chemicals
  • Acids
  • Caustic liquids
  • Potentially dangerous light radiation

However, businesses are not allowed to hand their employees a welding mask and call it a day! There is a selection process based on the workplace hazard employees are exposed to, and they also have to provide training for employees that includes the following topics:

  • Why the face and eye protection is necessary for their safety in the workplace
  • How the improper fit, use, or maintenance of their face and eye protection can compromise its effectiveness and potentially lead to injury
  • What the safety glasses can and cannot protect against as far as hazards in the workplace.
  • How to use safety glasses in case of a workplace emergency
  • How to inspect their safety glasses for damage, put them on, and remove them efficiently
  • How to properly maintain and store their safety glasses to prevent damage that could compromise their effectiveness
  • What medical signs and symptoms they need to watch for in case of exposure to the workplace hazard.
  • The general requirements of OSHA’s eye and face protection standards so they know what type of protective gear their employer is required to provide for them.

When Should You Use Safety Glasses?

There are all sorts of activities you should wear safety glasses for outside of the workplace. You should wear safety glasses anytime you’re exposing your eyes to debris or potential hazards. Potential hazards could include wind, UV rays, dust, debris, or potential impact. These hazards can lead to longer-term damage to your eyes that can cause chronic damage.

If you don’t wear proper eye protection during activities that could possibly expose your eyes to debris, it’s likely that eventually, a piece of debris will cause damage. This damage could span from temporary discomfort due to debris in the eye, to a scratched cornea, to the possible eventual development of a chronic condition that could lead to blindness. However, a much more common side effect of forgoing eyewear is the development of chronic dry eye.

According to the Mayo Clinic, chronic dry eye means that your tears will not be able to provide adequate lubrication for your eyes, which causes a variety of symptoms including discomfort, sensitivity to light, watery eyes, blurred vision, and difficulty seeing at night, among other things. In addition, chronic dry eyes can have the added complication of increasing the likelihood that you will develop eye infections. Eye infections can eventually cause long-term, permanent damage to your eyes, and if the root problem isn’t addressed, your vision could be permanently affected.

How to Pick the Best Safety Glasses for Your Activities

Beyond the workplace, there are plenty of situations where safety glasses should be worn! If you’ll be exposed to wind, debris, projectiles, or bright sunlight, it’s a good idea to incorporate eyewear into your plans. Choosing your eyewear depends heavily on the type of activity you’re planning on doing, and there are a few factors that should go into that.

Outdoor Sports

Prescription sports glasses are a great option for people who enjoy spending time being active in the great outdoors. But chasing a soccer ball or hitting a tennis ball across a court become harder under two conditions- if the sun is so bright you can’t see through the glare and if your prescription glasses won’t stay put! Sports glasses solve both problems by being designed for rigorous activity and providing UV protection. Additionally, they provide protection against the potential damage that a wayward tennis ball could cause.

There are a few things you should take into account if you’re looking for a new pair of sports protection glasses:

  • You need to choose the right prescription, of course. Without making sure your prescription is accurate, no matter what glasses you pick, they won’t work for you.
  • Physical comfort is one of the main features you’ll want to look for in a pair of prescription sports glasses. The last thing you want is for your eyewear to come loose at a crucial moment. Try on plenty of options to make sure that the glasses you choose actually stay on your head without causing you any level of discomfort.
  • Make sure they come with UV protection. Even the best prescription won’t matter if the glare from the sun hurts your eyes.
  • Make sure to check for warranty and returns policies to make sure you have options if it turns out the glasses don’t work for you.
  • Brand names mean reliability for a lot of people, which is a big reason why RX-Safety is so excited to be offering Oakley’s line of safety glasses. The brand is an important aspect of the product you’re investing in, and you can find a wide variety of brands on our site that will meet your prescription safety glasses needs.

Motorcycle Rides

Wearing glasses during your motorcycle ride protects your eyes from road debris, wind, and the sun, and there are a few options available depending on what kind of helmet you choose.

  • Regular Motorcycle Glasses– These are the perfect option for people who choose to wear full-face helmets. Full face helmets provide fantastic protection, but they might not give you the UV protection you need, and visors don’t come with prescriptions. Goggles can be too bulky to fit under a face shield. Motorcycle glasses are smaller and designed to work with full-face helmet types, so they’re a perfect option for people who opt for a full-face helmet.
  • Motorcycle Goggles– If you choose to use an open face helmet, you can and should use motorcycle goggles rather than motorcycle glasses to protect your eyes. Open face helmets have less coverage, obviously, so goggles offer both the protection you need from wind and debris as well as standard UV protection to protect your eyes from the sun.
  • Prescription Motorcycle Glasses– A pair of standard prescription glasses won’t protect your eyes from impact, wind, or debris the way a pair of motorcycle glasses will. Don’t try to use your glasses as a substitute for certified motorcycle glasses. A pair of prescription motorcycle glasses will keep your eyes fully protected and meet your prescription glasses requirements.

Your eyes are a delicate part of your face, aside from being the window to the soul. Long term damage resulting from a lack of proper eye protection is never worth the risk. Beyond discomfort and chronic dry-eye, the increased risk of infection can cause blindness, among other serious complications. Don’t ever risk eye damage when you’re being active and the great thing is that there are tons of stylish options that will protect your face without compromising your personal look. Whether you prefer Nike, Lacoste, Kate Spade, or our brand new Oakley line, there are plenty of options to suit both your lifestyle and your fashion preferences.

No matter what kind of activity you’re looking to protect your eyes during, RX-Safety has the perfect option for you! You can contact our experts here with questions about what kind of prescription safety glasses will work for you. We’d love to help!

Fruit Street Telehealth Platform Selected for Clinical Trial to Reduce Cognitive Decline andDementia Risk


Fruit Street Health, a digital health and telemedicine company, announced today that its platform has been selected by a research team at Brigham and Women’s Hospital (BWH), an affiliate of Harvard Medical School and a founding member of Partners HealthCare, to study different ways to improve brain healthy behaviors in individuals at risk for cognitive decline and dementia.

Over 5.8 million people in the United States alone have Alzheimer disease or related dementias (ADRDs), conditions which carry vast economic, societal, and personal burdens for health systems and families. Research has shown that up to 1/3 of the risk of ADRDs may be reduced by adopting brain healthy behaviors, including aerobic exercise, a Mediterranean diet, and engaging in socially and cognitively stimulating activities. Even while significant pharmaceutical research continues in efforts to delay or prevent dementia, the medical community, today, has evidence that lifestyle interventions are effective at reducing risk, in addition to having myriad benefits to overall health. “There is a giant gap between our knowledge of the behaviors that reduce dementia risk and our application of this knowledge in the delivery of care” said Dr. Seth Gale, investigator and neurologist at Brigham and Women’s Hospital.

Neurologists and primary care providers at the Brigham are planning a 6-month pilot study of older patients who are at a higher risk for dementia compared to their peers. Health coaches, allied with study participants’ providers, will employ Fruit Street’s digital platform to educate and motivate participants to achieve positive changes in brain healthy behaviors. In the study, coaches will take advantage of the platform’s fitness activity tracking, photographing of dietary intake, and two-way video and mobile messaging to guide participants in reaching individualized lifestyle goals. Measures of quality of life, sleep, cognitive function, physical activity, and diet among others, will be tracked over the 6-month study.

“We are excited to be contributing to this effort at Brigham and Women’s, where technology will be used directly to study the implementation of treatment recommendations,” said Laurence Girard, CEO of Fruit Street Health. “Dementia is a major public health burden and we are committed to finding innovative ways to help fight it.”

Fruit Street Health is a digital health and telemedicine company which currently licenses its software to healthcare professionals who wish to set up a virtual practice. It was the first company to deliver the Center for Disease Control & Prevention’s (CDC’s) National Diabetes Prevention Program (“DPP”), which has complimentary goals to those in the dementia risk reduction study being planned at BWH. Fruit Street’s HIPAA-compliant telehealth software is possible through a joint venture agreement with VSee, the world’s largest telemedicine video engine with more than three million users. Fruit Street and VSee collaborated to build a telemedicine product that helps healthcare providers conduct HIPAA compliant video calls and monitor the diet and lifestyle of patients using wearable devices and mobile applications. VSee is considered the gold standard for HIPAA compliant video conferencing in the telemedicine industry and offers the most bandwidth efficient video software in the world.

Share article on social media or email:

University Of Arkansas Releases Independent, Placebo Controlled Vasodilation Study Showing 1.5g Of Nitrosigine is Equal to 8g of Citrulline Malate


News Image

In attendance at this year’s ISSN (International Society of Sports Nutrition) Annual Conference, Nutrition 21 was excited to hear the significant results of an independent study presented by researchers from the University of Arkansas studying the significant blood flow impact of Nitrosigine®. The clinical study poster entitled “The Acute Effects of Citrulline Malate and Bonded Arginine Silicate Supplementation on Vasodilation of Young Adults” was presented by lead author Jeffrey Rogers from the University of Arkansas American College of Sports Medicine. Nutrition 21 provided no support and did not participate in the design or implementation of the study.

The study compared two popular ingredients used in sports nutrition today: citrulline malate (CM ) and bonded arginine silicate (Nitrosigine®). Nitrosigine® is a leading branded ingredient used in a variety of consumer products with a legacy of continued success in the sports nutrition and pre-workout arena. Nitrosigine® is added to formulations in order to significantly increase serum arginine and nitric oxide (NO) levels, reduce markers of post-workout muscle damage and increase cognitive processing speed. CM is used for its ability to increase blood serum concentrations of arginine, resulting in NO production.

Dr. Michelle Gray, Associate Professor and the Director of the Exercise Science Research Center at the University of Arkansas, commented “Current research has yet to compare CM and Nitrosigine® in vivo using a flow-mediated dilation (FMD) technique, a validated measure of the vascular endothelium’s NO producing ability. We identified a need and designed the experiment with the purpose of determining the effectiveness of Nitrosigine® and CM compared to placebo, in up-regulating NO production in blood vessels as measured by acute changes in vasodilation.”

The double-blind, placebo-controlled, crossover design study was performed, with a 7-day washout period between test visits. The subjects were 22 healthy, normotensive, and at least moderately active male (n=14) and female (n=8) young adults.

Results showed that a single dose of 1.5g of Nitrosigine® significantly increased FMD, a measurement of increased vasodilation, blood flow, and possibly nitric oxide levels, more than placebo (p<0.01) and to the same extent as 8g of CM.

Overall Clinical Results of the Study:


  • In a double-blind, placebo-controlled study, both Nitrosigine® and CM supplementation led to an equally significant increase in vasodilation and blood flow, but with a dose of CM (8g) that was 5x more than the dose of Nitrosigine (1.5g)
  • Overall, these data show that a single dose of 1.5g of Nitrosigine®:
  • Significantly increases vasodilation and blood flow, important for increases in muscle pump, as measured by FMD,in active young adults compared to placebo
  • Significantly increases FMD, a nitric oxide-related measurement, in active young adults compared to placebo
  • Significantly increases FMD, a measurement of vasodilation, blood flow, and nitric oxide production, as well as 8g of CM increases those metrics

“Nutrition 21 was excited to hear of this independent study and the positive results showing the benefits of Nitrosigine® on increasing vasodilation, a process driven by increasing nitric oxide production, and believed to enhance a number of sports performance endpoints. We are especially pleased that this study was designed to test a healthy, athletically trained population, and showed that a 1.5g dose of Nitrosigine® worked as well as 8g of Citrulline Malate, in increasing flow mediated dilation.” says James Komorowski, MS, CNS, Chief Science Office at Nutrition 21.

About Nitrosigine®: Nitrosigine® is a patented complex of bonded arginine silicate with FDA New Dietary Ingredient (NDI) notification status and has been self-affirmed Generally Recognized As Safe (GRAS) at the level of 1,500 mg per day for use in nutritional bars and beverages. Nitrosigine® is scientifically engineered to boost nitric oxide levels, which have been shown to be a key factor in generating greater blood flow and vasodilation in working muscles. The unique Nitrosigine® complex bonds arginine and silicate – unlocking powerful synergistic effects that offer enhanced benefits. Nitrosigine® is a safe, non-stimulant, effective ingredient that is easy to formulate into new and existing products for sports nutrition, men’s health and cardiovascular health.

About Nutrition 21, LLC: Nutrition 21, is an industry-leading developer and marketer of efficacious, high-value, clinically substantiated ingredients for use in dietary supplements, medical foods, and beverages. With over 30 years of biotechnology and pharmaceutical experience, the company’s scientific platform has continued to create unique, patented products that are both safe and clinically effective. To build consumer trust, Nutrition 21 ensures product efficacy and safety through a product development strategy that involves rigorous preclinical and clinical research. The company currently holds over 100 domestic and international issued and pending patents for its ingredients which support unique claims associated with glucose metabolism, weight management, cognition, and sports nutrition, among others. For more information, please visit: http://www.Nutrition21.com

© 2019 Nutrition 21, LLC Nitrosigine® is registered trademarks of Nutrition 21, LLC.

Nutrition 21, LLC, 1 Manhattanville Road, Suite 104, Purchase, New York 10577-2197 Source: Nutrition 21, LLC DRA2110100919

Share article on social media or email:

Benzer Goes Big in the Buckeye State with New Franchise Location in Columbus, Ohio


Benzer Pharmacy, a fast-growing chain of independent pharmacies headquartered in Tampa Bay, continues to turn its expansion efforts in a northbound-75 direction, now proudly welcoming a new store to its franchise family in Ohio—one located on W Town St./U.S. Highway 62 in Columbus.

Company officials have announced plans to hold an onsite grand opening celebration, including food and refreshments, kicking off at 9am on Wednesday, October 9th with an honorary ribbon-cutting ceremony to follow within the hour at 9:45am. Benzer notables Vinesh Darji, President of Benzer Franchise; and Tony Marakas, Vice President, will be on-hand to lead the proceedings, as joined by members of the Columbus Chamber.

For his part, Darji looks forward to the occasion being a memorable one as it represents another big step forward in “the biggest small town in America.”

“The more people learn about Benzer Pharmacy, the more there is to like,” Darji said. “This event gives us the perfect opportunity to spread the word about the brand and the benefits it brings to the table—things like free home delivery, shorter prescription-fill times of just 5-10 minutes on average, and the most competitive prices in town.”

Marakas continued, “Even better, Benzer offers free blister packaging, refill synchronization, and other customized medication pick-up options, as well as a host of clinical services ranging from medication therapy management and immunizations to diabetic consultation, smoking cessation support, and blood pressure screening, to name just a few.”

The new store will be led by veteran retail manager and store owner Tom Mox; and pharmacist-in-charge Terry Malone, a practicing pharmacist in central Ohio for the last 37 years.

“Both Tom and Terry share the Benzer commitment toward outstanding service with a strong emphasis on patient care and driving improvement in outcomes,” Darji explained. “Having them onboard will make all the difference in establishing a presence for the organization in Columbus that’s here today, and here to stay.”

The new Benzer Pharmacy Franchise will be open for business weekdays from 9am to 5pm, located at 867 W Town St., #103-104 in Columbus, Ohio 43222. Customers may reach the pharmacy by phone at 614-725-1340; Fax: 202-991-2612. All major insurances accepted.

For more information about Benzer Pharmacy, visit http://www.benzerpharmacy.com. To find a location nearest you, log on to http://www.benzerpharmacy.com/find-a-store/

###

About Benzer Pharmacy. Founded in 2009, Benzer Pharmacy is a chain of independent retail pharmacies specializing in compounding and specialty medication. Currently, there are 82 corporate-owned and 34 franchise locations situated throughout 29 states, including Florida, Michigan, Virginia, West Virginia, North Carolina, Tennessee, Texas, Georgia, Nevada, Louisiana, New York, Missouri, Mississippi, Maryland, Ohio, Indiana, and Idaho. Projections call for continued rapid growth as the organization seeks to substantially increase its customer base, while ensuring experiences match expectations at every touchpoint.

Benzer Pharmacy has made four straight appearances on Inc. 5,000 list of the fastest growing private companies in America from 2015-2018; correspondingly, the company earned 39th place on the 2015 Florida Fast 100 list, while concurrently placing 67th on the 2015 TBBJ 200 list of Tampa Bay’s largest private companies. Benzer was also voted favorite pharmacy in the 2015 Best of Fuquay Varina in North Carolina, and achieved PCAB compounding accreditation with Accreditation Commission for Health Care (ACHC). All Benzer Pharmacy medications require a doctor’s prescription.

Facebook: https://www.facebook.com/BenzerPharmacyFranchise/

LinkedIn: https://www.linkedin.com/company/benzer-pharmacy-franchising-llc/

SOURCE: Benzer Franchise

Share article on social media or email:

Stratodesk Collaborates with Teradici to Integrate PCoIP® Technology into NoTouch Software


News Image

Stratodesk NoTouch OS with Teradici PCoIP client icon.

“Stratodesk’s zero attack surface OS and management solution complements Teradici PCoIP technology and keeps security management at the forefront for enterprise users,” said David Smith, CEO for Teradici.

Stratodesk, the creator of the leading endpoint OS and management solution for IoT, DaaS and VDI, today announced its new collaboration with Teradici, the creator of industry-leading PCoIP® technology and Cloud Access Software, to bring the PCoIP Software Client for Linux into the NoTouch software product suite. The integration means that for the first time, Stratodesk NoTouch Clients can seamlessly connect to Teradici Cloud Access Software and Amazon Workspaces, a cloud desktop service that uses PCoIP protocol technology. With Teradici Cloud Access Software, Stratodesk customers will be able to connect to virtual desktops and deliver remotely hosted applications and data to end users with the combined and hardened security benefits of NoTouch endpoint computing and Teradici PCoIP technology.

“With the integration of Teradici PCoIP Software Client into NoTouch OS, our software is now capable of transforming virtually any device into a PCoIP endpoint,” said Stratodesk CEO, Emanuel Pirker. “This is just another example of how Stratodesk is innovating VDI by providing a wide range of VDI clients to our customers.”

Supported by Stratodesk’s participation in the Teradici Advantage Partner Program, the new integration enables enterprises to harness and benefit from:

  • Secure, high definition and highly responsive, PC-like computing experience.
  • Zero attack surface OS that replaces Windows and eliminates the need for malware/antivirus software.
  • Standardized endpoints that can be managed from one location via Stratodesk NoTouch Center.
  • Reduced hardware costs – existing and new devices can be upgraded with Stratodesk software with the PCoIP Client.


“Stratodesk’s zero attack surface OS and management solution complements Teradici PCoIP technology and keeps security management at the forefront for enterprise users,” said David Smith, CEO for Teradici. “Stratodesk software provides a flexible and comprehensive solution that allows system administrators to take full advantage of Teradici technology across their entire VDI deployment.”

The PCoIP protocol compresses, encrypts, and transmits virtual desktop display information in the form of pixels over a standard IP network to endpoint devices, ensuring maximum security. Meanwhile, Stratodesk software deploys directly onto endpoint de-vices bare metal, replacing Windows, eliminating the need for malware/anti-virus software, and preventing the installation of third party applications and common security exploits.

NoTouch converted Thin Clients, with the Teradici PCoIP Software Client included, are compatible with Teradici Cloud Access Software deployed in private data centers, AWS (including Amazon WorkSpaces), Google Cloud, and Microsoft Azure.

System administrators and IT managers can evaluate Stratodesk software for free (http://www.stratodesk.com/download), while the Teradici PCoIP Client is available to new and existing customers by purchasing a license from Stratodesk.

About Teradici

Teradici is the creator of the PCoIP® remoting protocol technology and Cloud Access Software. The company’s core mission is seamless and secure delivery of workstations and applications for end users. Teradici PCoIP technology and Cloud Access Software offer the most secure remoting solutions for public, private, and multicloud environments, enabling visualization of even the most graphics-intensive applications. The company’s solutions are deployed by Fortune 500 enterprises, government agencies, and service providers around the world.

Twitter: @Teradici

LinkedIn: https://www.linkedin.com/company/teradici/

About Stratodesk

Stratodesk is redefining end user computing by delivering an all-in-one solution for VDI, DaaS and IoT markets. Stratodesk’s cutting edge, linux-based OS and management suite, NoTouch, is a next generation, hardware-agnostic solution that enables companies to cost-effectively man-age their entire secure digital perimeter. Stratodesk’s solution works seamlessly across x86 and ARM/Raspberry Pi based hardware products to provide a unified platform for your endpoints. It also increases endpoint security, simplifies user experience and allows customers to maximize the benefits of existing desktop hardware through PC Repurposing.

Twitter: @stratodesk

Linkedin: https://www.linkedin.com/company/stratodesk/

PCoIP Ultra is a trademark of Teradici Corporation. Teradici and PCoIP are trademarks of Tera-dici Corporation and are registered in the United States and/or other countries. Any other trade-marks or registered trademarks mentioned in this release are the intellectual property of their respective owners.

Media Contacts

Carmen Mantalas

Blanc & Otus for Teradici

carmen.mantalas@blancandotus.com

Silke Telsnig

Head of Marketing

silke.telsnig@stratodesk.com

Share article on social media or email: